Super-Resolution Microscopy Reveals an Altered Fibrin Network in Cirrhosis: The Key Role of Oxidative Stress in Fibrinogen Structural Modifications.
cirrhosis
fibrin structure
fibrinogen oxidation
stimulated emission depletion (STED) microscopy
thrombus
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
12 Aug 2020
12 Aug 2020
Historique:
received:
16
06
2020
revised:
07
08
2020
accepted:
10
08
2020
entrez:
19
8
2020
pubmed:
19
8
2020
medline:
19
8
2020
Statut:
epublish
Résumé
Cirrhotic patients show a reduced synthesis of both pro- and anti-coagulant factors. Recent reports indicate that they are characterized by a higher risk of thrombotic rather than hemorrhagic complications, but the mechanisms conferring this risk are not fully elucidated. Oxidative-mediated fibrinogen modifications may explain, at least in part, a prothrombotic profile. The aim of the present pilot study was to investigate the alterations in fibrinogen structure and function in patients with cirrhosis of various severity and to correlate these findings with the mechanisms of thrombus formation. We assessed in plasma specific oxidative stress markers and measured oxidative modifications, functional and structural parameters in purified fibrinogen fractions obtained from cirrhotic patients and control subjects. We enrolled 15 cirrhotic patients (5 patients belonging to each of the three Child-Turcotte-Pugh classes) and 20 age- and sex-matched healthy controls. Plasma redox status, fibrinogen oxidative modifications, thrombin-catalyzed fibrin polymerization and fibrin resistance to plasmin-induced lysis were significantly altered in cirrhotic patients and were associated to disease severity. Importantly, clot structure obtained by stimulated emission depletion (STED) super-resolution microscopy indicated modifications in fiber diameter and in clot porosity in cirrhotic patients. Fibrin fiber diameter significantly decreased in cirrhotic patients when compared to controls, and this difference became more marked with disease progression. In parallel, fibrin pore size progressively decreased along with disease severity. In cirrhotic patients, fibrinogen clot analysis and oxidative-dependent changes reveal novel structural and functional fibrinogen modifications which may favor thrombotic complications in cirrhosis.
Identifiants
pubmed: 32806658
pii: antiox9080737
doi: 10.3390/antiox9080737
pmc: PMC7464401
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : This study was supported by "Fondi di Ateneo" research funding from the University of Florence to Matteo Becatti.
ID : -
Références
Am J Gastroenterol. 2013 Apr;108(4):568-74
pubmed: 23381015
Thromb Haemost. 2004 Feb;91(2):267-75
pubmed: 14961153
Antioxid Redox Signal. 2010 Jun 1;12(11):1295-331
pubmed: 19803748
J Thromb Haemost. 2013 Jun;11 Suppl 1:294-305
pubmed: 23809133
Hepatology. 2015 Feb;61(2):660-7
pubmed: 25284616
Blood. 2013 Mar 7;121(10):1712-9
pubmed: 23305734
Nat Protoc. 2006;1(6):2876-90
pubmed: 17406547
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):e88-99
pubmed: 21836064
Blood Coagul Fibrinolysis. 2017 Jul;28(5):356-364
pubmed: 27755019
Blood. 2010 Aug 12;116(6):878-85
pubmed: 20400681
Indian J Med Res. 2014 Feb;139(2):260-6
pubmed: 24718401
World J Gastroenterol. 2014 Mar 14;20(10):2564-77
pubmed: 24627592
Biophys J. 1992 Jul;63(1):111-28
pubmed: 1420861
J Thromb Haemost. 2016 May;14(5):1054-66
pubmed: 26833718
Diabetologia. 2005 Jun;48(6):1198-206
pubmed: 15864538
Blood. 2009 Nov 5;114(19):4272-8
pubmed: 19690336
Int J Cardiol. 2010 Dec 3;145(3):544-6
pubmed: 20537738
Circulation. 2016 Jan 19;133(3):302-11
pubmed: 26585672
Clin Chem. 2010 May;56(5):781-8
pubmed: 20348406
Circulation. 2018 Mar 13;137(11):1103-1113
pubmed: 29483085
J Diabetes Res. 2015;2015:456189
pubmed: 26357663
Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2567-73
pubmed: 16917107
Blood Coagul Fibrinolysis. 2002 Sep;13(6):533-9
pubmed: 12192305
Biomed Res Int. 2017;2017:8196256
pubmed: 28740853
Hepatology. 2006 Oct;44(4):1039-46
pubmed: 17006940
Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2700-6
pubmed: 26494231
PLoS One. 2012;7(2):e31756
pubmed: 22384068
Blood Coagul Fibrinolysis. 2016 Jan;27(1):1-4
pubmed: 26484638
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1355-61
pubmed: 24790138
Thromb Res. 2014 Sep;134(3):737-41
pubmed: 25074740
Free Radic Biol Med. 1994 Nov;17(5):429-37
pubmed: 7835749
N Engl J Med. 2011 Jul 14;365(2):147-56
pubmed: 21751907
J Thromb Haemost. 2007 Jul;5 Suppl 1:116-24
pubmed: 17635717
Am J Respir Crit Care Med. 2010 May 1;181(9):992-6
pubmed: 20075386
Br J Surg. 1973 Aug;60(8):646-9
pubmed: 4541913
Thromb Haemost. 1999 Nov;82(5):1482-9
pubmed: 10595642
Dig Liver Dis. 2020 Apr;52(4):374-391
pubmed: 32001151
J Thromb Haemost. 2016 Apr;14(4):784-93
pubmed: 26786481
World J Hepatol. 2015 Mar 27;7(3):443-59
pubmed: 25848469
J Trauma Acute Care Surg. 2013 Oct;75(4):699-703
pubmed: 24064886
Subcell Biochem. 2017;82:405-456
pubmed: 28101869
Dig Dis Sci. 2008 Nov;53(11):3012-7
pubmed: 18443906
J Biochem Pharmacol Res. 2013 Mar;1(1):15-26
pubmed: 23662248
Thromb Haemost. 2014 Nov;112(5):901-8
pubmed: 24899357
Biochemistry. 2003 Mar 11;42(9):2720-30
pubmed: 12614167
Clin Exp Immunol. 2019 Mar;195(3):322-333
pubmed: 30472725
Methods Mol Biol. 2019;1958:379-401
pubmed: 30945230
J Hepatol. 2011 Jun;54(6):1297-306
pubmed: 21145851
JHEP Rep. 2019 Jul 16;1(3):227-239
pubmed: 32039373
Int J Mol Sci. 2015 Nov 02;16(11):26087-124
pubmed: 26540040
Amino Acids. 2003 Dec;25(3-4):207-18
pubmed: 14661084
J Hepatol. 2007 Apr;46(4):727-33
pubmed: 17316874
Thromb Haemost. 2017 Jan 5;117(1):139-148
pubmed: 27761574